Matinas BioPharma Holdings Inc (NYSE American:MTNB)

0.6821
Delayed Data
As of May 13
 +0.0115 / +1.71%
Today’s Change
0.49
Today|||52-Week Range
1.61
-32.47%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues194.5K0.00149.7K119.8K
 
 
 
 
Depreciation And Amortization43.5K52.6K100.6K218.3K
 
 
 
 
 
 
Operating ExpensesGross Income---52.6K----
 
 
General Expenses9.2M8.2M16.6M14.5M
 
 
 
 
 
Research And Development5.3M3.9M9.0M6.8M
 
 
 
 
 
Total Operating Expenses9.3M8.3M16.7M14.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-9.1M-8.3M-16.5M-14.6M
 
 
 
 
 
Extraordinary Credit756.5K674.9K636.9K0.00
 
 
 
 
Extraordinary Charge-853.3K0.000.000.00
 
 
Interest Expense On Debt885.0016.5K0.000.00
 
 
 
Other Expenses20.5K0.0022.0K56.6K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-9.1M-7.6M-15.8M-14.6M
 
 
 
 
 
Income Taxes0.000.00-357.0K-506.9K
 
 
 
Preferred Dividend0.00-4.4M-608.3K-905.0K
 
 
 
 
Net Income-9.1M-7.6M-32.2M-14.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS51.5M57.7M90.5M98.1M
 
 
 
 
 
Shares To Calculate EPS Diluted51.5M57.7M90.5M98.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.18-$0.21-$0.36-$0.15
 
 
 
 
 
EPS Diluted-$0.18-$0.21-$0.36-$0.15